FHTX
Foghorn Therapeutics Inc.
Pharmaceutical PreparationsNasdaq<br>Emerging growth company
Total Trades
4
Buys
0
Sells
2
Largest Trade
$1M+
Insiders
2
Institutional Funds
58
Inst. Value
$1M+
Activist Filings
7
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Costa Carlos | Chief People Officer | EXERCISE | $100K–$500K | 37K | $3.72 | Sep 24, 2024 |
| Costa Carlos | Chief People Officer | SELL | $100K–$500K | 37K | $10.04 | Sep 24, 2024 |
| Agresta Samuel | Chief Medical Offi… | EXERCISE | $1M+ | 311K | $3.72 | Aug 18, 2023 |
| Agresta Samuel | Chief Medical Offi… | SELL | $1M+ | 311K | $8.25 | Aug 18, 2023 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 58 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RAYMOND JAMES FINANCIAL INC | 2.5M | $1M+ | SH |
| VANGUARD GROUP INC | 1.7M | $1M+ | SH |
| Siren, L.L.C. | 721K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 685K | $1M+ | SH |
| STATE STREET CORP | 619K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 298K | $1M+ | SH |
| Birchview Capital, LP | 282K | $1M+ | SH |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 269K | $1M+ | SH |
| Squarepoint Ops LLC | 142K | $500K+ | SH |
| JANE STREET GROUP, LLC | 116K | $500K+ | SH |
| SCS Capital Management LLC | 107K | $500K+ | SH |
| PANAGORA ASSET MANAGEMENT INC | 89K | $100K–$500K | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 82K | $100K–$500K | SH |
| Walleye Capital LLC | 81K | $100K–$500K | SH |
| BARCLAYS PLC | 63K | $100K–$500K | SH |
| Point72 Asset Management, L.P. | 62K | $100K–$500K | SH |
| GOLDMAN SACHS GROUP INC | 61K | $100K–$500K | SH |
| MORGAN STANLEY | 42K | $100K–$500K | SH |
| RHUMBLINE ADVISERS | 40K | $100K–$500K | SH |
| ALLIANCEBERNSTEIN L.P. | 27K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Flagship Ventures Fund V, L.P.
SC 13D/A · Jan 13, 2026
15.9%
9.3M shares
SC 13G/A · Feb 12, 2025
10.2%
5.7M shares
SC 13G/A · Oct 8, 2024
3.9%
2.1M shares
SC 13G · Sep 20, 2024
5.3%
2.9M shares
SC 13G/A · Jun 10, 2024
11.4%
6.3M shares
Biotechnology Value Fund, L.P.
SC 13G · May 30, 2024
5.5%
3.0M shares
Flagship Ventures Fund V, L.P. (2)
SC 13D/A · May 24, 2024
16.9%
9.3M shares